Penpulimab is highly active in relapsed/refractory classical Hodgkin's lymphoma June 11, 2021 No Comments
PDS-0101, M-9241 and bintrafusp alfa combination in advanced HPV16-positive malignancies June 9, 2021 No Comments
Early phase II results presented for ponatinib plus blinatumomab combination in Ph+ ALL patients June 9, 2021 No Comments
Aivita presents phase II data for its personalized GBM vaccine candidate, AV-GBM-1 June 9, 2021 No Comments
First-in-human study shows anti-ICOS KY-1044 well tolerated alone and with atezolizumab June 9, 2021 No Comments
RSS